Novopor Acquires Pressure Chemical to Expand Specialty Chemistry CDMO Platform

• Novopor Advanced Science has acquired Pressure Chemical Company to enhance its contract manufacturing capabilities in fine and specialty chemicals.

• The deal supports Novopor’s strategy to integrate early-stage development with commercial-scale production.

Novopor Advanced Science Private Limited, a CDMO focused on performance chemicals and material science, has acquired Pressure Chemical Company, a U.S.-based provider of high-pressure and specialty chemistry services. The financial details of the acquisition were not disclosed.

The deal aligns with Novopor’s strategy to create an integrated platform combining early-stage development with large-scale contract manufacturing. Founded in 1964 and headquartered in Pittsburgh, Pressure Chemical brings over 60 years of expertise in polymerisation, alkoxylation, and high-pressure chemistry. The company offers process development, piloting, and low-volume manufacturing for technically complex projects.

Radhesh Welling, CEO of Novopor, said the acquisition will “enhance our capabilities in complex chemistries, and create seamless access to large-scale fine and specialty manufacturing.” Sandra Cernick, President of Pressure Chemical, stated the partnership will allow further investment in people, facilities, and scale-up capabilities.

The integration is expected to expand Novopor’s facility footprint and strengthen its position in the specialty chemicals CDMO market. Advisors on the transaction included KPMG, PwC, and Wombat Capital for Novopor, and Fairmount Partners and Mazars for Pressure Chemical.

This acquisition marks a step forward in Novopor’s long-term goal to support clients from early innovation to commercial production in the contract manufacturing sector.